Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 20:7:36.
doi: 10.3389/fped.2019.00036. eCollection 2019.

Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation

Affiliations
Case Reports

Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation

Haiyan Li et al. Front Pediatr. .

Abstract

Cystic fibrosis (CF) is a relatively rare disease in Asians with various clinical characteristics, including CF-associated liver disease (CFLD), which is a common early non-pulmonary complication. This case report describes a Chinese CF patient harboring a homozygous nonsense mutation (c.1657C>T, p.R553X) who was failure to thrive and had intermittently diarrhea during the first year after birth. Liver function test of the patient showed the mildly and intermittently elevated alanine aminotransferase (ALT) levels ranging from 70 to 92 U/L and aspartate aminotransferase (AST) levels ranging from 80 to 90 U/L, which began at 8 months of age and lasted for 4 years without CF diagnosis. In addition, abdominal computed tomography (CT) revealed diffuse fatty infiltration of the liver at 4 years old and gradually developed hepatic cirrhosis. Subsequently, cirrhosis rapidly progressed with obvious splenomegaly and pancreatic insufficiency and the patient died of liver failure with coagulopathy by the age of 6 years old. Pediatricians should remain vigilant to avoid failure to diagnose CF, the occurrence of which may be underestimated, and pay greater attention to the patients with atypical clinical manifestations in Asian countries.

Keywords: CF transmembrane conductance regulator; CF-associated liver disease; cystic fibrosis; homozygous CFTR mutation; liver failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The images of CT and bronchoscopy in 2014, (A) maxillary sinuses were almost full of secretions, and (B) diffuse liver steatosis was observed. (C) Mild bilateral bronchiectasis was observed in CT, and (D) purulent secretions were observed in bronchoscopy.
Figure 2
Figure 2
The Sanger sequencing map of the nonsense mutation detected in the parents and patient.
Figure 3
Figure 3
The images of CT and bronchoscopy in 2016. (A) enlarged spleen and macronodular cirrhosis on the basis of diffuse hepatic steatosis and (B) fatty replacement of the atrophied pancreas indicated by white arrow were observed. (C) Mild bilateral bronchiectasis and (D) purulent secretions were observed.

Similar articles

Cited by

References

    1. Colombo C, Littlewood J. The implementation of standards of care in Europe: state of the art. J Cyst Fibros. (2011) 10 (Suppl. 2):S7–15. 10.1016/S1569-1993(11)60003-9 - DOI - PubMed
    1. Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments. Respirology (2015) 20:1172–81. 10.1111/resp.12656 - DOI - PubMed
    1. Xu J, Yin Y, Zhang L, Zhang J, Yuan S, Zhang H. Four case reports of Chinese cystic fibrosis patients and literature review. Pediatr Pulmonol. (2017) 52:1020–8. 10.1002/ppul.23744 - DOI - PubMed
    1. Elborn JS. Cystic fibrosis. Lancet (2016) 388:2519–31. 10.1016/S0140-6736(16)00576-6 - DOI - PubMed
    1. Palaniappan SK, Than NN, Thein AW, Moe S, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev. (2017) 8:CD012056. 10.1002/14651858.CD012056.pub2 - DOI - PMC - PubMed

Publication types

LinkOut - more resources